BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17194262)

  • 1. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
    Weber-Hamann B; Gilles M; Lederbogen F; Heuser I; Deuschle M
    J Clin Psychiatry; 2006 Dec; 67(12):1856-61. PubMed ID: 17194262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations.
    Deuschle M; Hamann B; Meichel C; Krumm B; Lederbogen F; Kniest A; Colla M; Heuser I
    J Clin Psychopharmacol; 2003 Apr; 23(2):201-5. PubMed ID: 12640223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
    Kopf D; Westphal S; Luley CW; Ritter S; Gilles M; Weber-Hamann B; Lederbogen F; Lehnert H; Henn FA; Heuser I; Deuschle M
    J Clin Psychopharmacol; 2004 Oct; 24(5):527-31. PubMed ID: 15349009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.
    Weber-Hamann B; Kratzsch J; Kopf D; Lederbogen F; Gilles M; Heuser I; Deuschle M
    J Psychiatr Res; 2007; 41(3-4):344-50. PubMed ID: 16497334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ; Verburg HF; Westerink AM; Assies J; Vaz FM; Koeter MW; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder.
    Ruhé HG; Khoenkhoen SJ; Ottenhof KW; Koeter MW; Mocking RJ; Schene AH
    Psychoneuroendocrinology; 2015 Feb; 52():261-71. PubMed ID: 25544738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.
    Paslakis G; Kopf D; Westphal S; Gilles M; Lederbogen F; Hamann B; Heuser I; Deuschle M
    J Psychopharmacol; 2011 Oct; 25(10):1344-6. PubMed ID: 20952454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice.
    Freed E; Goldney R; Lambert T; Tiller J; Johnston R
    Aust N Z J Psychiatry; 1999 Jun; 33(3):416-21. PubMed ID: 10442799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
    Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.
    Staner L; Kerkhofs M; Detroux D; Leyman S; Linkowski P; Mendlewicz J
    Sleep; 1995 Jul; 18(6):470-7. PubMed ID: 7481419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study.
    Ventura-Juncá R; Symon A; López P; Fiedler JL; Rojas G; Heskia C; Lara P; Marín F; Guajardo V; Araya AV; Sasso J; Herrera L
    BMC Psychiatry; 2014 Aug; 14():220. PubMed ID: 25086452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment.
    Weber-Hamann B; Blum WF; Kratzsch J; Gilles M; Heuser I; Deuschle M
    Pharmacopsychiatry; 2009 Jan; 42(1):23-8. PubMed ID: 19153943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine.
    Deuschle M; Luppa P; Gilles M; Hamann B; Heuser I
    Neuropsychobiology; 2004; 50(3):252-6. PubMed ID: 15365225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
    Pezzella G; Moslinger-Gehmayr R; Contu A
    Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bupropion on nocturnal urinary free cortisol and its association with antidepressant response.
    Rao U; Ott GE; Lin KM; Gertsik L; Poland RE
    J Psychiatr Res; 2005 Mar; 39(2):183-90. PubMed ID: 15589567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
    Miskovic M
    Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.